Proteasome inhibition decreases inflammation in human endothelial cells exposed to lipopolysaccharide

Journal of Cardiovascular Pharmacology

Volumn 60, Issue 4, 2012, Pages 381-389

  Lalu, Manoj M ^a   Xu, Han ^a   Sankaralingam, Sowndramalingam ^a,b   Davidge, Sandra T ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

endotoxin; nitrotyrosine; proteasome; septic shock; ubiquitin

Indexed keywords

3 NITROTYROSINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN 1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HYDROETHIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LACTACYSTIN; LIPOPOLYSACCHARIDE; PROTEASOME; PROTEOME; SUPEROXIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INFLAMMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEOMICS; STAINING; UBIQUITINATION; UPREGULATION;

ACETYLCYSTEINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GTP-BINDING PROTEIN BETA SUBUNITS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; RIBONUCLEOPROTEINS; UP-REGULATION;

EID: 84867744658     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182657eec     Document Type: Article

References (33)

1. In Focus: A National Look at Sepsis. Ottawa, ON: Canadian Institute of Health Information; 2009.
2. Opal SM. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol. 2007; 297:365-377.
3. Hough R, Pratt G, Rechsteiner M. Ubiquitin-lysozyme conjugates. Identification and characterization of an atp-dependent protease from rabbit reticulocyte lysates. J Biol Chem. 1986;261:2400-2408.
4. Li YF, Wang X. The role of the proteasome in heart disease. Biochim Biophys Acta. 2011;1809:141-149.
5. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on mhc class i molecules. Cell. 1994;78:761-771.
6. Tiao G, Fagan JM, Samuels N, et al. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mrna levels in rat skeletal muscle. J Clin Invest. 1994;94:2255-2264.
7. Callahan LA, Supinski GS. Sepsis-induced myopathy. Crit Care Med. 2009;37:S354-S367.
8. Arenas IA, Xu Y, Lopez-Jaramillo P, et al. Angiotensin ii-induced mmp-2 release from endothelial cells is mediated by tnf-alpha. Am J Physiol Cell Physiol. 2004;286:C779-C784.
9. Cuschieri J, Gourlay D, Garcia I, et al. Modulation of endotoxin-induced endothelial function by calcium/calmodulin-dependent protein kinase. Shock. 2003;20:176-182.
10. Yan W, Zhao K, Jiang Y, et al. Role of p38 mapk in icam-1 expression of vascular endothelial cells induced by lipopolysaccharide. Shock. 2002; 17:433-438.
11. Rees DD, Cellek S, Palmer RM, et al. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun. 1990;173:541-547.
12. Roth GA, Moser B, Krenn C, et al. Heightened levels of circulating 20s proteasome in critically ill patients. Eur J Clin Invest. 2005;35: 399-403.
13. Sankaralingam S, Xu Y, Sawamura T, Davidge ST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension. 2009;53:270-277.
14. Perkins DN, Pappin DJ, Creasy DM, et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20:3551-3567.
15. Palombella VJ, Rando OJ, Goldberg AL, et al. The ubiquitin-proteasome pathway is required for processing the nf-kappa b1 precursor protein and the activation of nf-kappa b. Cell. 1994;78:773-785.
16. Klaude M, Fredriksson K, Tjader I, et al. Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond). 2007;112:499-506.
17. Hobler SC, Tiao G, Fischer JE, et al. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. Am J Physiol. 1998;274:R30-R37.
18. Shen J, Reis J, Morrison DC, et al. Key inflammatory signaling pathways are regulated by the proteasome. Shock. 2006;25:472-484.
19. Dahlmann B. Role of proteasomes in disease. BMC Biochem. 2007 8 (suppl 1):S3.
20. Kroismayr R, Baranyi U, Stehlik C, et al. Herc5, a hect e3 ubiquitin ligase tightly regulated in lps activated endothelial cells. J Cell Sci. 2004;117:4749-4756.
21. Fischer D, Gang G, Pritts T, et al. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo. Biochem Biophys Res Commun. 2000;270:215-221.
22. Kisselev AF, Akopian TN, Castillo V, et al. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol Cell. 1999;4:395-402.
23. Qureshi N, Perera PY, Shen J, et al. The proteasome as a lipopolysaccharidebinding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events. J Immunol. 2003;171: 1515-1525.
24. Meiners S, Heyken D, Weller A, et al. Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J Biol Chem. 2003;278: 21517-21525.
25. Dauphinee SM, Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab Invest. 2006;86:9-22.
26. Lawson C, Wolf S. Icam-1 signaling in endothelial cells. Pharmacol Rep. 2009;61:22-32.
27. Xu J, Wu Y, Song P, et al. Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase i causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation. 2007;116:944-953.
28. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin ii uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 2005;102: 9056-9061.
29. Meiners S, Ludwig A, Lorenz M, et al. Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells. Free Radic Biol Med. 2006;40:2232-2241.
30. Bomsztyk K, Denisenko O, Ostrowski J. Hnrnp k: one protein multiple processes. Bioessays. 2004;26:629-638.
31. Treutiger CJ, Mullins GE, Johansson AS, et al. High mobility group 1 b-box mediates activation of human endothelium. J Intern Med. 2003; 254:375-385.
32. Dintilhac A, Bernues J. Hmgb1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. J Biol Chem. 2002; 277:7021-7028.
33. Levine MA, Modi WS, O'Brien SJ. Chromosomal localization of the genes encoding two forms of the g protein beta polypeptide, beta 1 and beta 3, in man. Genomics. 1990;8:380-386.